Showing results (221-230 of 304) with videos related to
Sort By:
Pageof 31
Gynecologic Oncology|November 13, 2019
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancerSara Gagno, Elena Poletto, Michele Bartoletti, et al.International Journal of Cancer|November 15, 2019
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trialMatteo Lambertini, Francesca Poggio, Marco Bruzzone, et al.European Journal of Cancer (Oxford, England : 1990)|November 13, 2024
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA studyChiara Molinelli, Marco Bruzzone, Eva Blondeaux, et al.Cancers|July 24, 2021
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal CancerSilvio Ken Garattini, Debora Basile, Marta Bonotto, et al.JAMA Oncology|July 13, 2023
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical TrialElisabetta Munzone, Meredith M Regan, Saverio Cinieri, et al.The Oncologist|July 1, 2025
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER)Carmine De Angelis, Martina Pagliuca, Emanuela Magnolfi, et al.Breast Cancer Research and Treatment|August 10, 2007
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancerValentina Guarneri, Antonio Frassoldati, Guido Ficarra, et al.JCO Precision Oncology|June 17, 2021
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast CancerLorenzo Gerratana, Andrew A Davis, Qiang Zhang, et al.Breast (Edinburgh, Scotland)|March 7, 2013
Gene expression profiling in breast cancer: a clinical perspectiveGrazia Arpino, Daniele Generali, Anna Sapino, et al.Healthcare (Basel, Switzerland)|December 30, 2025
A New Model for Bone Health Management in Postmenopausal Early Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy-The Predict & Prevent ProjectStefania Gori, Alessandra Fabi, Rossana Berardi, et al.Pageof 31